An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.

Schistosomiasis is a neglected tropical disease that is responsible for almost 300,000 deaths annually. Mass drug administration (MDA) is used worldwide for the control of schistosomiasis, but chemotherapy fails to prevent reinfection with schistosomes, so MDA alone is not sufficient to eliminate th...

Full description

Saved in:
Bibliographic Details
Main Authors: Soraya Gaze, Patrick Driguez, Mark S Pearson, Tiago Mendes, Denise L Doolan, Angela Trieu, Donald P McManus, Geoffrey N Gobert, Maria Victoria Periago, Rodrigo Correa Oliveira, Fernanda C Cardoso, Guilherme Oliveira, Rie Nakajima, Al Jasinskas, Chris Hung, Li Liang, Jozelyn Pablo, Jeffrey M Bethony, Philip L Felgner, Alex Loukas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-03-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1004033&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850022895679438848
author Soraya Gaze
Patrick Driguez
Mark S Pearson
Tiago Mendes
Denise L Doolan
Angela Trieu
Donald P McManus
Geoffrey N Gobert
Maria Victoria Periago
Rodrigo Correa Oliveira
Fernanda C Cardoso
Guilherme Oliveira
Guilherme Oliveira
Rie Nakajima
Al Jasinskas
Chris Hung
Li Liang
Jozelyn Pablo
Jeffrey M Bethony
Philip L Felgner
Alex Loukas
author_facet Soraya Gaze
Patrick Driguez
Mark S Pearson
Tiago Mendes
Denise L Doolan
Angela Trieu
Donald P McManus
Geoffrey N Gobert
Maria Victoria Periago
Rodrigo Correa Oliveira
Fernanda C Cardoso
Guilherme Oliveira
Guilherme Oliveira
Rie Nakajima
Al Jasinskas
Chris Hung
Li Liang
Jozelyn Pablo
Jeffrey M Bethony
Philip L Felgner
Alex Loukas
author_sort Soraya Gaze
collection DOAJ
description Schistosomiasis is a neglected tropical disease that is responsible for almost 300,000 deaths annually. Mass drug administration (MDA) is used worldwide for the control of schistosomiasis, but chemotherapy fails to prevent reinfection with schistosomes, so MDA alone is not sufficient to eliminate the disease, and a prophylactic vaccine is required. Herein, we take advantage of recent advances in systems biology and longitudinal studies in schistosomiasis endemic areas in Brazil to pilot an immunomics approach to the discovery of schistosomiasis vaccine antigens. We selected mostly surface-derived proteins, produced them using an in vitro rapid translation system and then printed them to generate the first protein microarray for a multi-cellular pathogen. Using well-established Brazilian cohorts of putatively resistant (PR) and chronically infected (CI) individuals stratified by the intensity of their S. mansoni infection, we probed arrays for IgG subclass and IgE responses to these antigens to detect antibody signatures that were reflective of protective vs. non-protective immune responses. Moreover, probing for IgE responses allowed us to identify antigens that might induce potentially deleterious hypersensitivity responses if used as subunit vaccines in endemic populations. Using multi-dimensional cluster analysis we showed that PR individuals mounted a distinct and robust IgG1 response to a small set of newly discovered and well-characterized surface (tegument) antigens in contrast to CI individuals who mounted strong IgE and IgG4 responses to many antigens. Herein, we show the utility of a vaccinomics approach that profiles antibody responses of resistant individuals in a high-throughput multiplex approach for the identification of several potentially protective and safe schistosomiasis vaccine antigens.
format Article
id doaj-art-ae73e03bc4144d068e71898b26df6950
institution DOAJ
issn 1553-7366
1553-7374
language English
publishDate 2014-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-ae73e03bc4144d068e71898b26df69502025-08-20T03:01:31ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742014-03-01103e100403310.1371/journal.ppat.1004033An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.Soraya GazePatrick DriguezMark S PearsonTiago MendesDenise L DoolanAngela TrieuDonald P McManusGeoffrey N GobertMaria Victoria PeriagoRodrigo Correa OliveiraFernanda C CardosoGuilherme OliveiraGuilherme OliveiraRie NakajimaAl JasinskasChris HungLi LiangJozelyn PabloJeffrey M BethonyPhilip L FelgnerAlex LoukasSchistosomiasis is a neglected tropical disease that is responsible for almost 300,000 deaths annually. Mass drug administration (MDA) is used worldwide for the control of schistosomiasis, but chemotherapy fails to prevent reinfection with schistosomes, so MDA alone is not sufficient to eliminate the disease, and a prophylactic vaccine is required. Herein, we take advantage of recent advances in systems biology and longitudinal studies in schistosomiasis endemic areas in Brazil to pilot an immunomics approach to the discovery of schistosomiasis vaccine antigens. We selected mostly surface-derived proteins, produced them using an in vitro rapid translation system and then printed them to generate the first protein microarray for a multi-cellular pathogen. Using well-established Brazilian cohorts of putatively resistant (PR) and chronically infected (CI) individuals stratified by the intensity of their S. mansoni infection, we probed arrays for IgG subclass and IgE responses to these antigens to detect antibody signatures that were reflective of protective vs. non-protective immune responses. Moreover, probing for IgE responses allowed us to identify antigens that might induce potentially deleterious hypersensitivity responses if used as subunit vaccines in endemic populations. Using multi-dimensional cluster analysis we showed that PR individuals mounted a distinct and robust IgG1 response to a small set of newly discovered and well-characterized surface (tegument) antigens in contrast to CI individuals who mounted strong IgE and IgG4 responses to many antigens. Herein, we show the utility of a vaccinomics approach that profiles antibody responses of resistant individuals in a high-throughput multiplex approach for the identification of several potentially protective and safe schistosomiasis vaccine antigens.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1004033&type=printable
spellingShingle Soraya Gaze
Patrick Driguez
Mark S Pearson
Tiago Mendes
Denise L Doolan
Angela Trieu
Donald P McManus
Geoffrey N Gobert
Maria Victoria Periago
Rodrigo Correa Oliveira
Fernanda C Cardoso
Guilherme Oliveira
Guilherme Oliveira
Rie Nakajima
Al Jasinskas
Chris Hung
Li Liang
Jozelyn Pablo
Jeffrey M Bethony
Philip L Felgner
Alex Loukas
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
PLoS Pathogens
title An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
title_full An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
title_fullStr An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
title_full_unstemmed An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
title_short An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
title_sort immunomics approach to schistosome antigen discovery antibody signatures of naturally resistant and chronically infected individuals from endemic areas
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1004033&type=printable
work_keys_str_mv AT sorayagaze animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT patrickdriguez animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT markspearson animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT tiagomendes animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT deniseldoolan animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT angelatrieu animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT donaldpmcmanus animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT geoffreyngobert animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT mariavictoriaperiago animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT rodrigocorreaoliveira animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT fernandaccardoso animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT guilhermeoliveira animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT guilhermeoliveira animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT rienakajima animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT aljasinskas animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT chrishung animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT liliang animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT jozelynpablo animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT jeffreymbethony animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT philiplfelgner animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT alexloukas animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT sorayagaze immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT patrickdriguez immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT markspearson immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT tiagomendes immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT deniseldoolan immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT angelatrieu immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT donaldpmcmanus immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT geoffreyngobert immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT mariavictoriaperiago immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT rodrigocorreaoliveira immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT fernandaccardoso immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT guilhermeoliveira immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT guilhermeoliveira immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT rienakajima immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT aljasinskas immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT chrishung immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT liliang immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT jozelynpablo immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT jeffreymbethony immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT philiplfelgner immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas
AT alexloukas immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas